Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT02419651
• Date of registration: 14/04/2015
• Prospective Registration: No
• Primary sponsor: Cairo University
• Public title: Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy
• Scientific title: Tramadol Versus Diclofenac for Reducing Pain Associated With Outpatient Hysteroscopy: A Randomized Double Blind Placebo-Controlled Trial
• Date of first enrolment: April 2015
• Target sample size: 210
• Recruitment status: Recruiting
• URL: https://clinicaltrials.gov/show/NCT02419651
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Care Provider).
• Phase: Phase 3

Countries of recruitment

Egypt

Contacts

• Name: AbdelGany MA Hassan, MRCOG, MD

Key inclusion & exclusion criteria

Inclusion Criteria:

- Indication to do outpatient hysteroscopy

- Consents to the procedure

- Postmenstrual

Exclusion Criteria:

- Known allergy to tramadol or diclofenac

- Cardiac renal or gastric disease.



Age minimum: 20 Years
Age maximum: 50 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Pain, Procedural

Pain, Post Procedural

Intervention(s)

Drug: Diclofenac

Drug: Tramadol

Drug: Placebo

Primary Outcome(s)

Pain during the procedure [Time Frame: 5 minutes after starting the procedure]

Secondary Outcome(s)

Pain after the procedure [Time Frame: 30 minutes after competing the procedure]

Secondary ID(s)

Hyst 3

Source(s) of Monetary Support

Please refer to primary and secondary sponsors